NR3C2 and glomerulosclerosis: Non-aldosterone-mediated activation of the mineralocorticoid receptor (MR) promotes reactive oxygen species generation and mediates tissue inflammation and fibrosis, leading to myocardial hypertrophy, ventricular remodeling, glomerular hypertrophy and glomerulosclerosis, ultimately causing renal-cardiac adverse outcomes [112,113].